Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?
- 13 April 2019
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 154 (1), 150-155
- https://doi.org/10.1016/j.ygyno.2019.04.006
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01CA136491)
This publication has 26 references indexed in Scilit:
- Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic MassObstetrics & Gynecology, 2011
- Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal massGynecologic Oncology, 2010
- Evaluation of the risk of malignancy index in daily clinical management of adnexal massesGynecologic Oncology, 2010
- Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the NetherlandsGynecologic Oncology, 2009
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massGynecologic Oncology, 2009
- Predictors of comprehensive surgical treatment in patients with ovarian cancerCancer, 2007
- Ovarian cancer: Patterns of surgical care across the United StatesGynecologic Oncology, 2006
- The effect of centralization of primary surgery on survival in ovarian cancer patientsObstetrics & Gynecology, 2003
- Sertoli Cell Tumor Causing Precocious Puberty in a Girl with Peutz-Jeghers SyndromeGynecologic Oncology, 1998
- A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1990